Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Risk modelling the mortality impact of antimicrobial resistance in secondary pneumococcal pneumonia infections during the 2009 influenza pandemic.

Identifieur interne : 000288 ( Main/Merge ); précédent : 000287; suivant : 000289

Risk modelling the mortality impact of antimicrobial resistance in secondary pneumococcal pneumonia infections during the 2009 influenza pandemic.

Auteurs : Carrie E. Barnes [Australie] ; C Raina Macintyre [Australie]

Source :

RBID : pubmed:31096052

Descripteurs français

English descriptors

Abstract

The aim of this study was to estimate the impact of antimicrobial resistance (AMR) in secondary pneumococcal pneumonia infections on global mortality during the 2009 influenza pandemic, to estimate future pandemic mortality risk and to inform pandemic preparedness.

DOI: 10.1016/j.ijid.2019.05.005
PubMed: 31096052

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:31096052

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Risk modelling the mortality impact of antimicrobial resistance in secondary pneumococcal pneumonia infections during the 2009 influenza pandemic.</title>
<author>
<name sortKey="Barnes, Carrie E" sort="Barnes, Carrie E" uniqKey="Barnes C" first="Carrie E" last="Barnes">Carrie E. Barnes</name>
<affiliation wicri:level="3">
<nlm:affiliation>School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia. Electronic address: carrie.barnes@dhhs.vic.gov.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Public Health and Community Medicine, University of New South Wales, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Macintyre, C Raina" sort="Macintyre, C Raina" uniqKey="Macintyre C" first="C Raina" last="Macintyre">C Raina Macintyre</name>
<affiliation wicri:level="3">
<nlm:affiliation>The Kirby Institute, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The Kirby Institute, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31096052</idno>
<idno type="pmid">31096052</idno>
<idno type="doi">10.1016/j.ijid.2019.05.005</idno>
<idno type="wicri:Area/PubMed/Corpus">000136</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000136</idno>
<idno type="wicri:Area/PubMed/Curation">000136</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000136</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000097</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000097</idno>
<idno type="wicri:Area/Ncbi/Merge">001F58</idno>
<idno type="wicri:Area/Ncbi/Curation">001F58</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001F58</idno>
<idno type="wicri:Area/Main/Merge">000288</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Risk modelling the mortality impact of antimicrobial resistance in secondary pneumococcal pneumonia infections during the 2009 influenza pandemic.</title>
<author>
<name sortKey="Barnes, Carrie E" sort="Barnes, Carrie E" uniqKey="Barnes C" first="Carrie E" last="Barnes">Carrie E. Barnes</name>
<affiliation wicri:level="3">
<nlm:affiliation>School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia. Electronic address: carrie.barnes@dhhs.vic.gov.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Public Health and Community Medicine, University of New South Wales, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Macintyre, C Raina" sort="Macintyre, C Raina" uniqKey="Macintyre C" first="C Raina" last="Macintyre">C Raina Macintyre</name>
<affiliation wicri:level="3">
<nlm:affiliation>The Kirby Institute, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The Kirby Institute, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</title>
<idno type="eISSN">1878-3511</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Anti-Bacterial Agents (pharmacology)</term>
<term>Coinfection (drug therapy)</term>
<term>Coinfection (epidemiology)</term>
<term>Coinfection (microbiology)</term>
<term>Coinfection (mortality)</term>
<term>Drug Resistance, Bacterial</term>
<term>Female</term>
<term>Humans</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza Vaccines (adverse effects)</term>
<term>Influenza, Human (complications)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics (prevention & control)</term>
<term>Pneumococcal Vaccines (administration & dosage)</term>
<term>Pneumococcal Vaccines (genetics)</term>
<term>Pneumococcal Vaccines (immunology)</term>
<term>Pneumonia, Pneumococcal (epidemiology)</term>
<term>Pneumonia, Pneumococcal (etiology)</term>
<term>Pneumonia, Pneumococcal (microbiology)</term>
<term>Pneumonia, Pneumococcal (mortality)</term>
<term>Streptococcus pneumoniae (drug effects)</term>
<term>Streptococcus pneumoniae (genetics)</term>
<term>Streptococcus pneumoniae (physiology)</term>
<term>Vaccination</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Antibactériens (pharmacologie)</term>
<term>Co-infection (microbiologie)</term>
<term>Co-infection (mortalité)</term>
<term>Co-infection (traitement médicamenteux)</term>
<term>Co-infection (épidémiologie)</term>
<term>Femelle</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Pandémies ()</term>
<term>Pneumonie à pneumocoques (microbiologie)</term>
<term>Pneumonie à pneumocoques (mortalité)</term>
<term>Pneumonie à pneumocoques (épidémiologie)</term>
<term>Pneumonie à pneumocoques (étiologie)</term>
<term>Résistance bactérienne aux médicaments</term>
<term>Streptococcus pneumoniae ()</term>
<term>Streptococcus pneumoniae (génétique)</term>
<term>Streptococcus pneumoniae (physiologie)</term>
<term>Vaccination</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Vaccins antigrippaux (effets indésirables)</term>
<term>Vaccins antipneumococciques (administration et posologie)</term>
<term>Vaccins antipneumococciques (génétique)</term>
<term>Vaccins antipneumococciques (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Influenza Vaccines</term>
<term>Pneumococcal Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Pneumococcal Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Pneumococcal Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Anti-Bacterial Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Vaccins antigrippaux</term>
<term>Vaccins antipneumococciques</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Streptococcus pneumoniae</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Coinfection</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Coinfection</term>
<term>Influenza, Human</term>
<term>Pneumonia, Pneumococcal</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Pneumonia, Pneumococcal</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Streptococcus pneumoniae</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Streptococcus pneumoniae</term>
<term>Vaccins antipneumococciques</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Vaccins antipneumococciques</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr">
<term>Co-infection</term>
<term>Pneumonie à pneumocoques</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en">
<term>Coinfection</term>
<term>Pneumonia, Pneumococcal</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en">
<term>Coinfection</term>
<term>Pneumonia, Pneumococcal</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr">
<term>Co-infection</term>
<term>Pneumonie à pneumocoques</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Antibactériens</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Streptococcus pneumoniae</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Streptococcus pneumoniae</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Influenza, Human</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Co-infection</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Co-infection</term>
<term>Grippe humaine</term>
<term>Pneumonie à pneumocoques</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Pneumonie à pneumocoques</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Drug Resistance, Bacterial</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Vaccination</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Grippe humaine</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Résistance bactérienne aux médicaments</term>
<term>Streptococcus pneumoniae</term>
<term>Vaccination</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The aim of this study was to estimate the impact of antimicrobial resistance (AMR) in secondary pneumococcal pneumonia infections on global mortality during the 2009 influenza pandemic, to estimate future pandemic mortality risk and to inform pandemic preparedness.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000288 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 000288 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:31096052
   |texte=   Risk modelling the mortality impact of antimicrobial resistance in secondary pneumococcal pneumonia infections during the 2009 influenza pandemic.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i   -Sk "pubmed:31096052" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1 

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021